Latest Articles

Publication Date
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - This is Money

GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug This is Money

Published: Nov. 21, 2025, 11:48 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - springermedicine.com

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression springermedicine.com

Published: Nov. 21, 2025, 2:26 a.m.
What Is the Role of ctDNA in Ovarian and Endometrial Cancers? - ASCO Daily News

What Is the Role of ctDNA in Ovarian and Endometrial Cancers? ASCO Daily News

Published: Nov. 21, 2025, 2:24 a.m.
Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report - Cureus

Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report Cureus

Published: Nov. 21, 2025, 1:57 a.m.
THBS1 identificated as an endometriosis biomarker through evidence from single-cell and bulk transcriptomic profiling.

Endometriosis affects a substantial number of women of reproductive age, yet current diagnostic methods rely on invasive procedures. To address this limitation, we investigated THBS1 as a potential biomarker and …

Published: Nov. 21, 2025, midnight
European Endometrial Ablation Market Outlook 2025-2035: Key Developments and Future Scope - openPR.com

European Endometrial Ablation Market Outlook 2025-2035: Key Developments and Future Scope openPR.com

Published: Nov. 20, 2025, 8:55 a.m.
Establishment and Characterization of a New Immortalized Human Adenomyosis Epithelial-Like Cell Line, tAEC21†.

Adenomyosis occurs when endometrial glands and stroma grow within the uterine myometrium. As a clinically significant disease, adenomyosis causes substantial pelvic pain and heavy menstrual bleeding. It remains understudied due …

Published: Nov. 20, 2025, midnight
Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis.

Endometriosis-associated ovarian carcinoma (EAOC) predominantly arises from the malignant transformation of endometriomas, yet the mechanism is incompletely defined. Spatial transcriptomic analysis of human specimens of normal endometrium, endometriomas, and EAOC …

Published: Nov. 20, 2025, midnight
Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors - Nature

Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors Nature

Published: Nov. 19, 2025, 2:27 p.m.
Endometrial Cancer Risk Models: Insights and Limits - Bioengineer.org

Endometrial Cancer Risk Models: Insights and Limits Bioengineer.org

Published: Nov. 19, 2025, 2:21 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!